Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-25-028225

Options or other derivatives

  • Chief Financial Officer returned 706,588 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

O'Loughlin Steve · Chief Financial Officer

Table II: Derivative

9 lines
Date Transaction Shares Owned after D/I
2025-03-31 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −3,333 0 D
2025-03-31 Returned to the company : show line 2 in the form Stock Option (Right to Buy) −1,666 0 D
2025-03-31 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −3,333 0 D
2025-03-31 Returned to the company : show line 4 in the form Stock Option (Right to Buy) −8,833 0 D
2025-03-31 Returned to the company : show line 5 in the form Stock Option (Right to Buy) −13,333 0 D
2025-03-31 Returned to the company : show line 6 in the form Stock Option (Right to Buy) −59,066 0 D
2025-03-31 Returned to the company : show line 7 in the form Stock Option (Right to Buy) −107,463 0 D
2025-03-31 Returned to the company : show line 8 in the form Stock Option (Right to Buy) −256,438 0 D
2025-03-31 Returned to the company : show line 9 in the form Stock Option (Right to Buy) −253,123 0 D
Loading xslF345X05/ownership.xml…